Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Total Costs & Expenses
$15.33B
TTM · Period ending: · USD
TEVA Total Costs & Expenses
Latest reported$15.33Bperiod ending
Latest reported$15.33Bperiod ending
TEVA TTM Total Costs & Expenses (-$79.30M → $15.33B)
TTM Total Costs & Expenses
High-resolution chart · PNG
TEVA total costs & expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 1,556,914,000 | |
| 1,505,332,000 | |
| 1,374,644,000 | |
| 1,350,386,000 | |
| 1,244,254,000 | |
| 1,118,096,000 | |
| 1,083,460,000 | |
| 1,016,200,000 | |
| 1,010,300,000 | |
| 984,800,000 | |
| 971,100,000 | |
| -223,000,000 | |
| -486,600,000 | |
| -710,100,000 | |
| -943,100,000 | |
| -824,500,000 | |
| -824,500,000 | |
| -824,500,000 | |
| -824,500,000 | |
| -552,500,000 | |
| -552,500,000 | |
| -552,500,000 | |
| -552,500,000 | |
| -481,000,000 | |
| -481,000,000 | |
| -481,000,000 | |
| -481,000,000 | |
| -414,000,000 | |
| -414,000,000 | |
| -414,000,000 | |
| -414,000,000 | |
| -350,700,000 | |
| -350,700,000 | |
| -350,700,000 | |
| -350,700,000 | |
| -275,000,000 | |
| -275,000,000 | |
| -275,000,000 | |
| -275,000,000 | |
| -288,700,000 | |
| -288,700,000 | |
| -288,700,000 | |
| -288,700,000 | |
| -236,900,000 | |
| -236,900,000 | |
| -236,900,000 | |
| -236,900,000 | |
| -188,600,000 | |
| -188,600,000 | |
| -188,600,000 | |
| -188,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -79,300,000 | |
| -79,300,000 | |
| -79,300,000 |